Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Edmund Harrigan | Director | 2024-03-28 | 413 | $56.97 | $23.53kBuy |
Paul J. Clancy | Director | 2024-03-28 | 403 | $56.97 | $22.96kBuy |
Christiana Stamoulis | EVP Chief Financial Officer | 2024-02-12 | 387 | $57.84 | $22.38kSell |
Jonathan Elliott Dickinson | EVP General Manager Europe | 2024-01-22 | 108 | $61.50 | $6.64kSell |
Michael James Morrissey | EVP Head of Tech. Operations | 2024-01-22 | 108 | $61.50 | $6.64kSell |
Jonathan Elliott Dickinson | EVP General Manager Europe | 2024-01-19 | 122 | $61.49 | $7.50kSell |
Michael James Morrissey | EVP Head of Tech. Operations | 2024-01-19 | 122 | $61.49 | $7.50kSell |
Michael James Morrissey | EVP Head of Tech. Operations | 2024-01-18 | 11,359 | $61.18 | $694.94kBuy |
Jonathan Elliott Dickinson | EVP General Manager Europe | 2024-01-18 | 8,114 | $61.18 | $496.41kBuy |
Jonathan Elliott Dickinson | EVP General Manager Europe | 2024-01-17 | 101 | $61.48 | $6.21kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Baker Bros Advisors LP | 16.11% | 36,179,122 | $1.88B | Institution |
Blackrock Inc | 10.82% | 24,298,022 | $1.26B | Institution |
Vanguard Group Inc | 10.03% | 22,519,381 | $1.17B | Institution |
Julian Baker | 8.84% | 19,851,744 | $1.03B | Insider |
Dodge Cox | 7.17% | 16,090,421 | $835.41M | Institution |
Baker Brothers Life Sciences LP | 5.54% | 12,445,783 | $646.19M | Insider |
Baker Brothers Life Sciences Capital GP LLC | 5.54% | 12,430,783 | $645.41M | Insider |
State Street Corp | 4.51% | 10,120,170 | $525.44M | Institution |
Renaissance Technologies LLC | 2.47% | 5,553,937 | $288.36M | Institution |
Baker Biotech Capital GP LLC | 2.19% | 4,911,003 | $254.98M | Insider |